Argemone oil induces genotoxicity in mice

References

• Aggarwal KC, Prasad MS, Salhan RN, et al. (2001). A two-center collaborative study on clinicoepidemiological profile of a recent outbreak of epidemic dropsy in New Delhi (India) with special emphasis on its cardiac manifestations in pediatric patients. J Trop Pediatr 47:291–294
   PubMed Web of Science ®Google Scholar
• Ansari KM, Chauhan LKS, Dhawan A, et al. (2004). Unequivocal evidence of genotoxic potential of argemone oil in mice. Int J Cancer 112:890–895
   PubMed Web of Science ®Google Scholar
• Ansari KM, Dhawan A, Khanna SK, Das M. (2005). In vivo DNA damaging potential of sanguinarine alkaloid, isolated from argemone oil, using alkaline Comet assay in mice. Food Chem Toxicol 43:147–153
   PubMed Web of Science ®Google Scholar
• Babu CK, Khanna SK, Das M. (2006). Safety evaluation studies on argemone oil through dietary exposure for 90 days in rats. Food Chem Toxicol 44:1151–1157
   PubMed Web of Science ®Google Scholar
• Bhatt M, Shah U. (2014). On poisonous plant but medicinally active Argemone mexicana. J Med Pharm Allied Sci 3:20–28
   Google Scholar
• Bose PK. (1972). A new colorimetric method for estimation of argemone oil. J Am Oil Chem Soc 49:201–202
   Web of Science ®Google Scholar
• Brahmachari G, Gorai D, Roy R. (2013). Argemone mexicana: chemical and pharmacological aspects. Braz J Pharmacog 23:559–575
   Google Scholar
• Das A, Mukherjee A, Chakrabarti J. (2004). Sanguinarine: an evaluation of in vivo cytogenetic activity. Mutat Res 563:81–87
   PubMed Web of Science ®Google Scholar
• Das M, Ansari KM, Dhawan A, et al. (2005). Correlation of DNA damage in epidemic dropsy patients to carcinogenic potential of argemone oil and isolated sanguinarine alkaloid in mice. Int J Cancer 117:709–717
   PubMed Web of Science ®Google Scholar
• Das M, Khanna SK. (1997). Clinicoepidemiological, toxicological, and safety evaluation studies on argemone oil. Crit Rev Toxicol 27:273–297
   PubMed Web of Science ®Google Scholar
• Das S, Kumar GS, Ray A, Maiti M. (2003). Spectroscopic and thermodynamic studies on the binding of sanguinarine and berberine to triple and double helical DNA and RNA structures. J Biomol Struct Dyn 20:703–714
   PubMed Web of Science ®Google Scholar
• Dhaker SK, Jain V, Bharati D. (2015). Spleno protective activity of Argemone mexicana Linn. against aniline induced splenic toxicity in rats. Res Chronicle Health Sci 1:60–67
   Google Scholar
• El gamal AA, Mohamed OSA, Khalid SA. (2008). Toxicity of Argemone mexicana seed, seed oil and their extracts on albino rats. J Sci Technol 8:97–104
   Google Scholar
• Guízar-González C, Trujillo-Villanueva K, Monforte-González M, Vázquez-Flota F. (2012). Sanguinarine and dihydrosanguinarine accumulation in Argemone mexicana (L) cell suspension cultures exposed to yeast extract. J Mex Chem 56:19–22
   Web of Science ®Google Scholar
• Husain S, Narsimha R, Rao RN. (1999). Separation, identification and determination of sanguinarine in argemone and other adulterated edible oils by reversed-phase high-performance liquid chromatography. J Chromatogr A 863:123–126
   PubMed Web of Science ®Google Scholar
• Ivett JL, Tice RR. (1982). Average generation time: a new method for analyzing cellular proliferation kinetics based on bromodeoxyuridine-dependent chromosomal differential staining patterns. Environ Mutagen 4:358
   Google Scholar
• Margolin BH, Resnick MA, Rimpo JY, et al. (1986). Statistical analysis for in vivo cytogenetic assays using Chinese hamster ovary cells. Environ Mutagen 8:183–204
   PubMedGoogle Scholar
• McFee AF, Lowe K, San Sebastian JR. (1983). Improved sister chromatid differentiation using paraffin-coated bromodeoxyuridine tablets in mice. Mutat Res 119:83–88
   PubMed Web of Science ®Google Scholar
• McFee AF, Tice RR. (1990). Influence of treatment to sacrifice time and the presence of BrdUrd on chemically-induced aberration rates in mouse marrow cells. Mutat Res 241:95–108
   PubMed Web of Science ®Google Scholar
• Mir AM, Mustafa M, Mir BA, Kumar A. (2014). Determination of physicochemical parameters of fixed oils of Argemone mexicana. Indo Am J Pharm Res 4:1538–1543
   Google Scholar
• Mishra V, Mishra M, Ansari KM, et al. (2012). Edible oil adulterants, argemone oil and butter yellow, as aetiological factors for gall bladder cancer. Eur J Cancer 48:2075–2085
   PubMed Web of Science ®Google Scholar
• Mishra V, Mishra M, Chaudhari BP, et al. (2014). Argemone oil and butter yellow induced toxicity in hepatic and extra hepatic tissues. Bioenergetics 3:111
   Google Scholar
• Mukherjee A, Giri AK, Sharma A, Talukder G. (1988). Relative efficacy of short-term tests in detecting genotoxic effects of cadmium chloride in mice in vivo. Mutat Res 206:285–295
   PubMed Web of Science ®Google Scholar
• Murthi TN, Sharma M, Devdhara VD. (1988). High pressure liquid chromatographic determination of argemone oil in edible oil. J Food Sci Technol 25:170–172
   Web of Science ®Google Scholar
• Porwal L, Chauhan RRS, Bhatia GS, Srivastava S. (2001). Acute and short term toxicity study of argemone oil on some hematological parameters in albino rat (Rattus norvegicus). Sci Cult 67:119–120
   Google Scholar
• Preston RJ, Dean BJ, Galloway SM, et al. (1987). Mammalian in vivo cytogenetic assays: analysis of chromosome aberration in bone marrow cells. Mutat Res 189:157–165
   PubMed Web of Science ®Google Scholar
• Rajvaidhya S, Nagori BP, Singh GK, et al. (2012). A review on Argemone mexicana Linn. – an Indian medicinal plant. IJPSR 3:2494–2501
   Google Scholar
• Rukmini C. (1971). Sanguinarine potentiating factor in argemone oil. Indian J Med Res 59:1676–1680
   PubMed Web of Science ®Google Scholar
• Sarkar SN. (1948). Isolation from argemone oil of dihydrosanguinarine and sanguinarine; toxicity of sanguinarine. Nature 162:265–268
   PubMed Web of Science ®Google Scholar
• Schmeller T, Latz-Bruning B, Wink M. (1997). Biochemical activities of berberine, palmatine and sanguinarine mediating chemical defence against microorganisms and herbivores. Phytochemistry 44:257–266
   PubMed Web of Science ®Google Scholar
• Schneider EL, Tice RR, Kram D. (1978). Bromodeoxyuridine differential chromatid staining technique: a new approach to examining sister chromatid exchange and cell replication kinetics. In: Prescott DM, ed. Methods in cell biology. Volume II. New York: Acedemic Press, 379–409
   Google Scholar
• Singh R, Farisi MM, Singh K, et al. (1999). Epidemic dropsy in the eastern region of Nepal. J Trop Pediatr 45:8–13
   PubMed Web of Science ®Google Scholar
• Sokal RR, Rohlf FJ. (1981). Biometry: the principles and practice of statistics in biological research. 3rd ed. New York: W. H. Freeman and Co
   Google Scholar
• Sourabie TS, Nikiema JB, Nacoulma OG. (2014). Monographycal survey of pharmacological potentials of Argemone mexicana L. (Papaveraceae), a plant of Burkina Faso Pharmacopeia: determination of antihepatotoxic and antipyretic activities. Int J Res Pharm Biosci 1:1–10
   Google Scholar
• Tandon S, Das M, Khanna K. (1993). Effect of sanguinarine on the transport of essential nutrients in an everted gut sac model: role of Na+–K + ATPase. Nat Toxins 1:835–840
   Google Scholar
• Tice RR, Ivett JL, McFee AF. (1987a). The effect of agent treatment time on the induction of sister chromatid exchanges in mouse bone marrow cells in vivo. Mutat Res 182:15–29
   PubMed Web of Science ®Google Scholar
• Tice RR, Luke CA, Shelby M. (1987b). Methyl isocyanate: an evaluation of in vivo cytogenetic activity. Environ Mutagen 9:37–58
   PubMedGoogle Scholar
• Veni T, Pushpanathan T. (2014). Investigations of antimicrobial and phytochemical analysis of Argemone mexicana medicinal plant extracts against bacteria with gastrointestinal relevance. Asian J Pharm Clin Res 7:93–97
   Google Scholar
• Verma R, Sachdeva S, Sudhir, et al. (2014). Clinico-epidemiological investigation of an epidemic dropsy outbreak in a village of Haryana, India. Indian J Public Health Res Dev 5:72–77
   Google Scholar
• World Health Organization. (1985). Environmental Health Criteria 46: Guidelines for the Study of Genetic Effects in Human Populations. Geneva, Switzerland: WHO
   Google Scholar